Table 3.
Pathways predicted to be enriched in 623 target genes/proteins.
| Pathway | Description | Count in Network |
Strength | |
|---|---|---|---|---|
| KE | mmu04010 | MAPK signaling pathway | 20 of 287 | 0.40 |
| mmu04014 | Ras signaling pathway | 17 of 225 | 0.44 | |
| mmu04015 | Rap1 signaling pathway | 18 of 208 | 0.50 | |
| mmu04068 | FoxO signaling pathway | 15 of 129 | 0.63 | |
| mmu04151 | PI3K-Akt signaling pathway | 23 of 353 | 0.38 | |
| mmu04152 | AMPK signaling pathway | 11 of 124 | 0.51 | |
| mmu04510 | Focal adhesion | 17 of 225 | 0.45 | |
| mmu04930 | Type II diabetes mellitus | 7 of 48 | 0.73 | |
| mmu04931 | Insulin resistance | 10 of 109 | 0.52 | |
| mmu04960 | Aldosterone-regulated sodium reabsorption | 6 of 38 | 0.76 | |
| WK | WP2841 | Focal adhesion: PI3K-Akt-mTOR signaling pathway | 24 of 316 | 0.44 |
| WP85 | Focal adhesion | 15 of 185 | 0.47 | |
Focal adhesion is a common keyword in three pathways (bold in the pathway column), and PI3K-Akt(-mTOR) is a common keyword in two pathways (bold). Among four pathways, WP2841 contains these two keywords (bold in the description column).